{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:18:05Z","timestamp":1788967085983,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2023QB055"],"award-info":[{"award-number":["ZR2023QB055"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.bioorg.2025.108939","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T23:04:17Z","timestamp":1756767857000},"page":"108939","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Discovery of Bicyclo[1.1.1]pentane-based Olaparib derivatives as novel PARP inhibitors: A dual-action strategy targeting DNA damage and immune activation"],"prefix":"10.1016","volume":"165","author":[{"given":"Binzhuo","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangzhao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongshuang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weilong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiguo","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kairui","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.108939_bb0005","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/s41573-020-0076-6","article-title":"Poly (ADP-ribose) polymerase inhibition: past, present and future","volume":"19","author":"Curtin","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2025.108939_bb0010","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1111\/febs.15518","article-title":"Progress and outlook in studying the substrate specificities of PARPs and related enzymes","volume":"288","author":"Suskiewicz","year":"2021","journal-title":"FEBS J."},{"key":"10.1016\/j.bioorg.2025.108939_bb0015","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1126\/science.aam7344","article-title":"PARP inhibitors: synthetic lethality in the clinic","volume":"355","author":"Lord","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2025.108939_bb0020","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41568-022-00535-5","article-title":"Targeting DNA damage response pathways in cancer","volume":"23","author":"Groelly","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioorg.2025.108939_bb0025","first-page":"141","article-title":"A pan-tumor review of the role of poly (adenosine diphosphate ribose) polymerase inhibitors","volume":"75","author":"Hage Chehade","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bioorg.2025.108939_bb0030","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1038\/s41467-018-05588-5","article-title":"PARP2 mediates branched poly ADP-ribosylation in response to DNA damage","volume":"9","author":"Chen","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2025.108939_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116804","article-title":"An update on small molecule compounds targeting synthetic lethality for cancer therapy","volume":"278","author":"Luo","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108939_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117937","article-title":"Poly(ADP-ribose) polymerase-1 (PARP1)-based dual inhibitors targeting cancer synthetic lethality (2022-present): advances and perspectives","volume":"297","author":"Ye","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108939_bb0045","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/s44321-025-00214-6","article-title":"PARP7 as a new target for activating anti-tumor immunity in cancer","volume":"17","author":"Popova","year":"2025","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bioorg.2025.108939_bb0050","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202216235","article-title":"Thioparib inhibits homologous recombination repair, activates the type I IFN response, and overcomes olaparib resistance","volume":"15","author":"Wang","year":"2023","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bioorg.2025.108939_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.116803","article-title":"Parps in immune response: potential targets for cancer immunotherapy","volume":"234","author":"Wang","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108939_bb0060","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1200\/JCO.2021.39.15_suppl.3000","article-title":"A first-in-human phase 1 study of a novel PARP7 inhibitor RBN-2397 in patients with advanced solid tumors","volume":"39","author":"Falchook","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bioorg.2025.108939_bb0065","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.ccell.2021.06.018","article-title":"PARP7 negatively regulates the type I interferon response in cancer cells and its inhibition triggers antitumor immunity","volume":"39","author":"Gozgit","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bioorg.2025.108939_bb0070","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00044-025-03375-8","article-title":"Olaparib research update: mechanism, structure and clinical trials","volume":"34","author":"Che","year":"2025","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2025.108939_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216367","article-title":"PARPing up the right tree; an overview of PARP inhibitors for metastatic castration-resistant prostate cancer","volume":"577","author":"Slootbeek","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bioorg.2025.108939_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108188","article-title":"Role of PARP-1 structural and functional features in PARP-1 inhibitors development","volume":"156","author":"Merkuryev","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108939_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107469","article-title":"Discovery of highly potent PARP7 inhibitors for cancer immunotherapy","volume":"148","author":"Yang","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108939_bb0090","doi-asserted-by":"crossref","first-page":"12284","DOI":"10.1021\/acs.jmedchem.3c00821","article-title":"YCH1899, a highly effective phthalazin-1(2H)-one derivative that overcomes resistance to prior PARP inhibitors","volume":"66","author":"Sun","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108939_bb0095","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1021\/acs.jmedchem.3c02096","article-title":"Discovery and proof of concept of potent dual Pol\u03b8\/PARP inhibitors for efficient treatment of homologous recombination-deficient tumors","volume":"67","author":"Ma","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108939_bb0100","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s00044-022-02919-6","article-title":"Recent advances in structural types and medicinal chemistry of PARP-1 inhibitors","volume":"31","author":"Yu","year":"2022","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2025.108939_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116535","article-title":"Poly (ADP-ribose) polymerase (PARP) inhibitors as anticancer agents: an outlook on clinical progress, synthetic strategies, biological activity, and structure-activity relationship","volume":"274","author":"Das","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108939_bb0110","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1021\/acs.jmedchem.8b00576","article-title":"Examination of diazaspiro cores as piperazine bioisosteres in the olaparib framework shows reduced DNA damage and cytotoxicity","volume":"61","author":"Reilly","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108939_bb0115","doi-asserted-by":"crossref","first-page":"15106","DOI":"10.1021\/acs.joc.9b01947","article-title":"Difluoro-substituted bicyclo[1.1.1]pentanes for medicinal chemistry: design, synthesis, and characterization","volume":"84","author":"Bychek","year":"2019","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2025.108939_bb0120","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1039\/C8OB02812E","article-title":"Saturated bioisosteres of benzene: where to go next?","volume":"17","author":"Mykhailiuk","year":"2019","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2025.108939_bb0125","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/s41586-020-2060-z","article-title":"Copper-mediated synthesis of drug-like bicyclopentanes","volume":"580","author":"Zhang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2025.108939_bb0130","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1021\/jm300094u","article-title":"Application of the bicyclo[1.1.1]pentane motif as a nonclassical phenyl ring bioisostere in the design of a potent and orally active \u03b3-secretase inhibitor","volume":"55","author":"Stepan","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108939_bb0135","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1021\/acsmedchemlett.6b00281","article-title":"Investigation of a Bicyclo[1.1.1]pentane as a phenyl replacement within an LpPLA(2) inhibitor","volume":"8","author":"Measom","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.108939_bb0140","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1021\/acsmedchemlett.7b00018","article-title":"Toward resolving the resveratrol conundrum: synthesis and in vivo pharmacokinetic evaluation of BCP-resveratrol","volume":"8","author":"Goh","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.108939_bb0145","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1021\/acs.jmedchem.3c01764","article-title":"Discovery of highly selective PARP7 inhibitors with a novel scaffold for Cancer immunotherapy","volume":"67","author":"Gu","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108939_bb0150","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1021\/acs.jmedchem.2c01452","article-title":"Discovery of the potent and highly selective PARP7 inhibitor as a novel immunotherapeutic agent for tumors","volume":"66","author":"Gu","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108939_bb0155","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.cels.2017.09.015","article-title":"Orchestration of DNA damage checkpoint dynamics across the human cell cycle","volume":"5","author":"Chao","year":"2017","journal-title":"Cell Syst."},{"key":"10.1016\/j.bioorg.2025.108939_bb0160","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.3390\/molecules29061407","article-title":"Discovery of novel 4-Hydroxyquinazoline derivatives: in silico, in vivo and in vitro studies using primary PARPi-resistant cell lines","volume":"29","author":"Zhu","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.108939_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2018.101084","article-title":"ROS and the DNA damage response in cancer","volume":"25","author":"Srinivas","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.bioorg.2025.108939_bb0170","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1200\/JCO.2024.42.16_suppl.3123","article-title":"BY101921: restoring interferon signaling and anti-tumor immunity through PARP7 inhibition","volume":"42","author":"Yu","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bioorg.2025.108939_bb0175","doi-asserted-by":"crossref","first-page":"4950","DOI":"10.1021\/acs.jmedchem.4c00090","article-title":"Design, synthesis, and structure-activity relationship of novel pyridazinone-based PARP7\/HDACs dual inhibitors for elucidating the relationship between antitumor immunity and HDACs inhibition","volume":"67","author":"Duan","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108939_bb0180","doi-asserted-by":"crossref","first-page":"14095","DOI":"10.1021\/acs.jmedchem.3c01152","article-title":"Discovery of quinazoline-2,4(1H,3H)-dione derivatives containing a piperizinone moiety as potent PARP-1\/2 inhibitorsdesign, synthesis, in vivo antitumor activity, and X-ray crystal structure analysis","volume":"66","author":"Zhou","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108939_bb0185","doi-asserted-by":"crossref","first-page":"12069","DOI":"10.1021\/acs.jmedchem.3c00640","article-title":"Discovery, synthesis, and evaluation of novel dual inhibitors of a vascular endothelial growth factor receptor and poly(ADP-ribose) polymerase for BRCA wild-type breast cancer therapy","volume":"66","author":"Li","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108939_bb0190","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1021\/jm301825t","article-title":"Design, synthesis, and biological evaluation of a series of benzo[de][1,7]naphthyridin-7(8H)-ones bearing a functionalized longer chain appendage as novel PARP1 inhibitors","volume":"56","author":"Ye","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108939_bb0195","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13062-020-00267-2","article-title":"AMDock: a versatile graphical tool for assisting molecular docking with Autodock Vina and Autodock4","volume":"15","author":"Vald\u00e9s-Tresanco","year":"2020","journal-title":"Biol. Direct"},{"key":"10.1016\/j.bioorg.2025.108939_bb0200","doi-asserted-by":"crossref","first-page":"W463","DOI":"10.1093\/nar\/gkaf361","article-title":"PLIP 2025: Introducing protein-protein interactions to the protein-ligand interaction profiler","volume":"53","author":"Schake","year":"2025","journal-title":"Nucleic Acids Res."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825008193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825008193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T20:24:57Z","timestamp":1760559897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825008193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":40,"alternative-id":["S0045206825008193"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108939","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of Bicyclo[1.1.1]pentane-based Olaparib derivatives as novel PARP inhibitors: A dual-action strategy targeting DNA damage and immune activation","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108939","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108939"}}